Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-25 @ 2:01 AM
NCT ID:
NCT06145360
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 35 years or older, diagnosed with Type 2 Diabetes Mellitus,
* Specifically, individuals with a documented HbA1c level equal to or exceeding 8.5% over the course of the last six months or more are considered eligible candidates.
* these patients should currently be undergoing treatment involving a combination of Insulin and either Metformin or Sitagliptin.
Exclusion Criteria:
* Patients with a history of recurrent urinary tract infections
* those who are currently pregnant are excluded from participation in the study.
* patients with an estimated Glomerular Filtration Rate (eGFR) exceeding 40 ml/min/1.73m²,
* Furthermore, individuals with other concurrent medical conditions, and those who are unable to provide informed consent for the study, have also been excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
70 Years
Study:
NCT06145360
Study Brief:
Protocol Section:
NCT06145360